Patents by Inventor Stephen Murfin

Stephen Murfin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrrolopyrimidines for pharmaceutical compositions
    Patent number: 8697713
    Abstract: The present invention relates to novel pyrrolopyrimidine compounds of the general formula (1) and pharmaceutical compositions comprising said pyrrolopyrimidine compounds. Moreover, the present invention relates to the use of the pyrrolopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Grant
    Filed: July 10, 2007
    Date of Patent: April 15, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Stefan Jäkel, Tanja Reuter, Stephen Murfin, Thomas Stephen Coulter, Steven Taylor
  • Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions
    Patent number: 8633201
    Abstract: The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Grant
    Filed: April 10, 2007
    Date of Patent: January 21, 2014
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Babette Aicher, Thomas Stephen Coulter, Stefan Jaekel, Arndt-René Kelter, Stephen Murfin, Tanja Reuter, Steven Taylor
  • Mnk1 or Mnk2 inhibitors
    Patent number: 8071607
    Abstract: The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Grant
    Filed: December 22, 2005
    Date of Patent: December 6, 2011
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Stephen Coulter, Steven Taylor, Stephen Murfin, Valery Thammalaksa, Babette Aicher, Stefan Jaekel, Tanja Reuter
  • THIENOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100143341
    Abstract: The present invention relates to novel pharmaceutical compositions of general formula (I) comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Application
    Filed: June 21, 2006
    Publication date: June 10, 2010
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventors: Steven Taylor, Stephen Murfin, Thomas Stephen Coulter, Stefan Jakel, Babette Aicher, Arndt-Rene Kelter, Joachim Kraemer, Christian Kirchhoff, Andreas Scheel, Julian Woelcke
  • PYRROLOPYRIMIDINES FOR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100105708
    Abstract: The present invention relates to novel pyrrolopyrimidine compounds of the general formula (1) and pharmaceutical compositions comprising said pyrrolopyrimidine compounds. Moreover, the present invention relates to the use of the pyrrolopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Application
    Filed: July 10, 2007
    Publication date: April 29, 2010
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventors: Stefan Jäkel, Tanja Reuter, Stephen Murfin, Thomas Stephen Coulter, Steven Taylor
  • THIENOPYRIMIDINES HAVING MNK1/MNK2 INHIBITING ACTIVITY FOR PHARMACEUTICAL COMPOSITIONS
    Publication number: 20100056548
    Abstract: The present invention relates to novel pharmaceutical compositions comprising thienopyrimidine compounds. Moreover, the present invention relates to the use of the thienopyrimidine compounds of the invention for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Application
    Filed: April 10, 2007
    Publication date: March 4, 2010
    Applicant: DEVELOGEN AKTIENGESELLSCHAFT
    Inventors: Babette Aicher, Thomas Stephen Coulter, Stefan Jaekel, Arndt-René Kelter, Stephen Murfin, Tanja Reuter, Steven Taylor
  • MNK1 or MNK2 Inhibitors
    Publication number: 20090163520
    Abstract: The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2a or Mnk2b) and/or variants thereof.
    Type: Application
    Filed: December 22, 2005
    Publication date: June 25, 2009
    Inventors: Thomas Stephen Coulter, Stephen Taylor, Stephen Murfin, Valery Thammalaksa, Babette Aicher, Stefan Jaekel, Tanja Reuter